Instrument Inactif

Communiqués Hospira, Inc.

Actions

US4410601003

Produits pharmaceutiques

Cours en clôture NYSE Autres places de cotation
- ^USD	-

28/08/15	Activision Blizzard et United Continental intègrent le S&P-500	RE
24/08/15	Apple : Les valeurs à suivre à Wall Street	RE

Communiqués

27/08/15	Hospira : Announces First Installation of Plum 360™ Infusion System With Hospira MedNet™	PU
27/08/15	Hospira : Announces First Installation of Plum 360(TM) Infusion System With Hospira MedNet(TM)	PR
21/08/15	Hospira : Expert committee BACKS Hospira’s InflectraTM	PU
20/08/15	Hospira : Charleston Area Medical Center Integrates Smart Pump Technology to Advance Patient Safety	PR
20/08/15	Hospira : TGA Approves First mAb Biosimilar	PR
13/08/15	Hospira : Applauds UK's NICE for Issuing Adoption Resource to Help Drive the Introduction of Biosimilars	PU
16/07/15	Hospira : Announces U.S. Launch of Generic Bivalirudin for Injection	PR
15/07/15	Hospira : to Announce Second-Quarter 2015 Results on July 29, 2015	PR
10/06/15	Hospira : New results from first real-world study show comparable effectiveness and safety of Hospira's Inflectra™ (infliximab) in patients with rheumatic diseases switched from reference infliximab, Remicade™	PU
10/06/15	Hospira : New results from first real-world study show comparable effectiveness and safety of Hospira's Inflectra(TM) (infliximab) in patients with rheumatic diseases switched from reference infliximab, Remicade(TM)	PR
02/06/15	Hospira : ANVISA Approves First Infliximab Biosimilar in Brazil	PU
20/05/15	Hospira : Alliance for Health Reform Bring Food and Drug Administration, Industry Experts Together to Discuss the Future of Biosimilars in the United States	PR
13/05/15	Hospira : Shareholders Approve Merger of Hospira and Pfizer at Special Meeting	PR
01/05/15	Hospira : Statement On FDA's Final Biosimilar Guidance Documents	PU
24/04/15	Hospira : Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation	PR
13/04/15	Hospira : Hope for Greater Access for Patients to Biosimilar Medicines	PR
07/04/15	Hospira : to Announce First-Quarter 2015 Results on April 28, 2015	PR
30/03/15	Hospira : INFLECTRA(TM) (Infliximab) Now Available in Canada	PR
27/03/15	Hospira : Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen	PR
06/03/15	Hospira : Inflectra™ (infliximab) patient registry reports interim results in the treatment of inflammatory bowel disease	PU
06/03/15	Hospira : Statement on FDA Approval of the First Biosimilar in the United States	PR
19/02/15	Hospira : Inflectra(TM) (infliximab) patient registry reports interim results in the treatment of inflammatory bowel disease	PR
18/02/15	HOSPIRA : SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout	BU
18/02/15	HOSPIRA : SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of the Hospira, Inc. (HSP) Board of Directors in Connection to the Proposed Sale of the Company to Pfizer, Inc.	BU
16/02/15	Hospira : launches first biosimilar monoclonal antibody (mAb) Inflectra™ (infliximab) in major European markets	PU